Holen Sie sich die Stockscreener-App
53.98
0.55%
-0.30
Handel nachbörslich:
53.98
Schlusskurs vom Vortag:
$54.28
Offen:
$54.27
24-Stunden-Volumen:
1.27M
Relative Volume:
0.95
Marktkapitalisierung:
$7.77B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-766.63M
KGV:
-9.4617
EPS:
-5.7051
Netto-Cashflow:
$-712.55M
1W Leistung:
-3.97%
1M Leistung:
-5.83%
6M Leistung:
+70.02%
1J Leistung:
-29.10%
1-Tages-Spanne:
$53.53
$54.77
1-Wochen-Bereich:
$53.24
$57.90
52-Wochen-Spanne:
$27.66
$76.61
Vaxcyte Inc Stock (PCVX) Company Profile
Firmenname
Vaxcyte Inc
Sektor
Branche
Telefon
650-837-0111
Adresse
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Compare PCVX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
53.98 | 7.81B | 0 | -766.63M | -712.55M | -5.7051 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Bestätigt | Needham | Buy |
| 2025-09-12 | Eingeleitet | Goldman | Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Eingeleitet | Goldman | Buy |
| 2023-12-07 | Eingeleitet | Mizuho | Buy |
| 2023-04-18 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-03 | Bestätigt | Needham | Buy |
| 2022-12-15 | Eingeleitet | Guggenheim | Buy |
| 2022-11-17 | Eingeleitet | BTIG Research | Buy |
| 2021-12-29 | Fortgesetzt | Jefferies | Buy |
| 2021-06-24 | Fortgesetzt | Jefferies | Buy |
| 2020-07-07 | Eingeleitet | BofA Securities | Buy |
| 2020-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-07-07 | Eingeleitet | Needham | Buy |
Alle ansehen
Vaxcyte Inc Aktie (PCVX) Neueste Nachrichten
Insider Sell: Elvia Cowan Sells 1,892 Shares of Vaxcyte Inc (PCVX) - GuruFocus
Insider Sell: Elvia Cowan Sells 1,892 Shares of Vaxcyte Inc (PCV - GuruFocus
Vaxcyte publishes VAX-31 phase 1/2 study results in Lancet By Investing.com - Investing.com South Africa
Vaxcyte (PCVX) Advances VAX-31 Vaccine with Positive Study Resul - GuruFocus
Vaxcyte (NASDAQ:PCVX) CAO Sells $105,138.44 in Stock - MarketBeat
Vaxcyte (PCVX) Price Target Decreased by 17.52% to 83.49 - MSN
Vaxcyte : March Investor Presentation (6862ba) - marketscreener.com
Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate - The Manila Times
Vaxcyte publishes VAX-31 phase 1/2 study results in Lancet - Investing.com UK
Vaxcyte Advances VAX-31 into Phase 3 Clinical Program Following Positive Phase 1/2 Study Results in Older Adults - Quiver Quantitative
Vaxcyte publishes positive Vax-31 phase 1/2 adult study results in The Lancet Infectious Diseases - marketscreener.com
A 31-strain pneumonia shot showed strong immune responses in adults 50+ - Stock Titan
Vaxcyte SVP, finance & CAO Cowan sells $105k in stock - Investing.com India
Vaxcyte Publishes Positive Vax-31 Phase 1/2 Adult Study Results In The Lancet Infectious Diseases - TradingView
Positive VAX-31 Phase 1/2 Adult Data Published in The - GlobeNewswire
Vaxcyte (PCVX) finance SVP sells 1,892 shares under 10b5-1 plan - Stock Titan
Vaxcyte Completes $632.5 Million Public Offering of Common Stock - Global Legal Chronicle
Elvia Cowan sells shares; RSU vesting at PCVX (NASDAQ: PCVX) - Stock Titan
Forecast Cut: Is Vaxcyte Inc affected by consumer sentimentPortfolio Return Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
Vaxcyte, Inc. $PCVX Shares Sold by Aquatic Capital Management LLC - MarketBeat
HighVista Strategies LLC Acquires 53,345 Shares of Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte, Inc. $PCVX Shares Acquired by Boothbay Fund Management LLC - MarketBeat
PCVX Technical Analysis & Stock Price Forecast - Intellectia AI
Vaxcyte to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on February 24, 2026 - Quantisnow
Love a little risk? Wall Street sees massive upside in Vaxcyte stock - MSN
Pivotal bioVenture Partners Boosts Stake in Vaxcyte - National Today
Pivotal bioVenture Partners Investment Advisor LLC Raises Stock Position in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte Inc Stock (ISIN: US92242T1016) Slides on Major Investor Stake Cut - AD HOC NEWS
Vaxcyte Shares Decline as Capital Research Global Investors Reduces Stake - National Today
Vaxcyte, Inc. $PCVX Holdings Lowered by Capital Research Global Investors - MarketBeat
Victory Capital Management Inc. Lowers Stock Holdings in Vaxcyte, Inc. $PCVX - MarketBeat
Aug PostEarnings: Can Vaxcyte Inc continue delivering strong returnsQuarterly Market Review & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Vaxcyte (NASDAQ:PCVX) CAO Elvia Cowan Sells 2,500 Shares - MarketBeat
Vaxcyte (PCVX) officer surrenders shares to cover RSU taxes - Stock Titan
Vaxcyte (PCVX) CEO surrenders 3,685 shares to cover RSU taxes - Stock Titan
Vaxcyte (PCVX) CFO uses 1,021 shares to cover RSU tax withholding - Stock Titan
Vaxcyte (PCVX) finance SVP exercises options and sells 2,500 shares - Stock Titan
Vaxcyte (PCVX) COO logs planned stock sales and RSU tax withholding - Stock Titan
Jefferies reiterates Vaxcyte stock Buy rating on regulatory clarity By Investing.com - Investing.com South Africa
Jefferies Maintains Buy on Vaxcyte (PCVX) March 10, 2026 - Meyka
PCVX (NASDAQ: PCVX) Form 144: insider notice to sell RSU shares - Stock Titan
Jefferies reiterates Vaxcyte stock Buy rating on regulatory clarity - Investing.com UK
Understanding the Setup: (PCVX) and Scalable Risk - Stock Traders Daily
Vaxcyte’s Heavy Equity Raise and Wider Losses Could Be A Game Changer For Vaxcyte (PCVX) - simplywall.st
Neo Ivy Capital Management Has $2.99 Million Stock Position in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
BTIG Reiterates Vaxcyte (PCVX) Buy Recommendation - MSN
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vaxcyte (PCVX), Universal Health (UHS) and MoonLake Immunotherapeutics (MLTX) - The Globe and Mail
Vaxcyte (PCVX) CFO awarded RSUs and options, surrenders shares for taxes - Stock Titan
Vaxcyte (NASDAQ: PCVX) SVP granted options, RSUs and surrenders shares for taxes - Stock Titan
Vaxcyte Earnings Call: Cash Strength, Trials Accelerate - TipRanks
Finanzdaten der Vaxcyte Inc-Aktie (PCVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):